These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16504834)

  • 21. A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.
    Davidson JA; McMorn SO; Waterhouse BR; Cobitz AR
    Clin Ther; 2007 Sep; 29(9):1900-14. PubMed ID: 18035190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk assessment in diabetes mellitus: comparison of the general Framingham risk profile versus the World Health Organization/International Society of Hypertension risk prediction charts in Arabs--clinical implications.
    Al-Lawati JA; Barakat MN; Al-Lawati NA; Al-Maskari MY; Elsayed MK; Mikhailidis DP; Al-Zakwani IS
    Angiology; 2013 Jul; 64(5):336-42. PubMed ID: 22942129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between depressive symptoms and cardiovascular risk factors among selected Latino patients at a community clinic.
    Glassy CM; Lemus H; Cronan T; Glassy MS; Talavera GA
    Psychol Health Med; 2010 Mar; 15(2):117-26. PubMed ID: 20391229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.
    Zhou H; Zhang C; Ni J; Han X
    BMC Endocr Disord; 2019 Oct; 19(1):98. PubMed ID: 31601203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
    Ginsberg HN; MacCallum PR
    J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global cardiovascular disease risk assessment in United States adults with diabetes.
    Wong ND; Glovaci D; Wong K; Malik S; Franklin SS; Wygant G; Iloeje U
    Diab Vasc Dis Res; 2012 Apr; 9(2):146-52. PubMed ID: 22377485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study.
    Shen BJ; Goldberg RB; Llabre MM; Schneiderman N
    Ann Epidemiol; 2006 Feb; 16(2):131-7. PubMed ID: 16257230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of vascular disease in premenopausal women with diabetes mellitus.
    García NH; Pérez HA; Spence JD; Armando LJ
    Clin Ther; 2014 Dec; 36(12):1924-1934. PubMed ID: 24998421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.
    Carr DB; Utzschneider KM; Hull RL; Tong J; Wallace TM; Kodama K; Shofer JB; Heckbert SR; Boyko EJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2006 Sep; 29(9):2078-83. PubMed ID: 16936156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
    Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
    Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS).
    Hadaegh F; Khalili D; Fahimfar N; Tohidi M; Eskandari F; Azizi F
    J Endocrinol Invest; 2009 Oct; 32(9):724-30. PubMed ID: 19574728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women.
    Howard BV; Criqui MH; Curb JD; Rodabough R; Safford MM; Santoro N; Wilson AC; Wylie-Rosett J
    Metabolism; 2003 Mar; 52(3):362-71. PubMed ID: 12647277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
    López-Jaramillo P; Barbosa E; Molina DI; Sanchez R; Diaz M; Camacho PA; Lanas F; Pasquel M; Accini JL; Ponte-Negretti CI; Alcocer L; Cobos L; Wyss F; Sebba-Barroso W; Coca A; Zanchetti A;
    J Hypertens; 2019 Jun; 37(6):1126-1147. PubMed ID: 30882601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome.
    Maple-Brown L; Cunningham J; Celermajer DS; O'Dea K
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):419-25. PubMed ID: 17302878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population.
    Hari P; Nerusu K; Veeranna V; Sudhakar R; Zalawadiya S; Ramesh K; Afonso L
    Metab Syndr Relat Disord; 2012 Feb; 10(1):47-55. PubMed ID: 21999397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.